DM1 can be seen as an RNA-toxicity disease, in which the nuclear accumulation of aberrant DMPK mRNA transcripts harboring the CTG repeat expansion, lead to a secondary spliceopathy. This evidence concerns the gene DMPK and myotonic dystrophy type 1.